Usa covid-19 vaccine Volunteers medicines Usa

Moderna Covid vaccine well-tolerated, generates immune response in older adults

Reading now: 874
www.livemint.com

COVID-19 vaccine co-developed by researchers at the US National Institute of Allergy and Infectious Diseases (NIAID), and the American biotech company Moderna have shown that it is well-tolerated and generates a strong immune response in older adults.The study, published in the New England Journal of Medicine, noted that the experimental vaccine, mRNA-1273, was well-tolerated by the older trial participants, who were over 55 years of age.According to the researchers from NIAID, older adults are more vulnerable to complications of COVID-19, and are an important population for vaccination.They said understanding how the vaccine affects this section of the population is a critical part of measuring its safety and efficacy.The Phase 1 trial.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA